Loading...

APC anti-mouse CD3 Antibody APC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APC_073012
C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
  • 17A2_APC_073012
    C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100235 25 µg NOK273
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100236 100 µg NOK636
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Liu J, et al. 2019. Immunity. 50:600. PubMed
  3. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  4. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  5. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  6. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  7. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  8. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  9. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  10. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  11. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  12. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  13. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  14. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  15. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  16. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  17. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  18. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  19. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  20. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  21. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  22. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  23. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  24. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  25. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  26. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  27. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  28. Li X, et al. 2022. Cell. 185:1709. PubMed
  29. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  30. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  31. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  32. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  33. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  34. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  35. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  36. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  37. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  38. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  39. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  40. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  41. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  42. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  43. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  44. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  45. Cansever D, et al. 2023. Nat Immunol. . PubMed
  46. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  47. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  48. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  49. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  50. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  51. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  52. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  53. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  54. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  55. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  56. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  57. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  58. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  59. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  60. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  61. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  62. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  63. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  64. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  65. Baram T, et al. 2021. Cells. 10:. PubMed
  66. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  67. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  68. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  69. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  70. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  71. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  72. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  73. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  74. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  75. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  76. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  77. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  78. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  79. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  80. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  81. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  82. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  83. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  84. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  85. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  86. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  87. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  88. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  89. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  90. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  91. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  92. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  93. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  94. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  95. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  96. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  97. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  98. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  99. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  100. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  101. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  102. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  103. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  104. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  105. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  106. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  107. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  108. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  109. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  110. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  111. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  112. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  113. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  114. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  115. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  116. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  117. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  118. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  119. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  120. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  121. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  122. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  123. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  124. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  125. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  126. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  127. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  128. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  129. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  130. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  131. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  132. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  133. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  134. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  135. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  136. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  137. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  138. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  139. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  140. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  141. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  142. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  143. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  144. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  145. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  146. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  147. Zhang J, et al. 2018. Nature. 553:91. PubMed
  148. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  149. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  150. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  151. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  152. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  153. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  154. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  155. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  156. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  157. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  158. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  159. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  160. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  161. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  162. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  163. Kim S, et al. 2020. Autophagy. :1. PubMed
  164. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  165. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  166. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  167. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  168. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  169. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  170. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  173. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  174. Li H, et al. 2022. iScience. 25:104481. PubMed
  175. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  176. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  177. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  178. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  179. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  180. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  181. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  182. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  183. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  184. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  185. Zeng A, et al. 2020. Oncol Rep. . PubMed
  186. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  187. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  188. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  189. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  190. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  191. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  192. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  193. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  194. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  195. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  196. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  197. Liu J, et al. 2019. Immunity. 50:600. PubMed
  198. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  199. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  200. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  201. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  202. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  203. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  204. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  205. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  206. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  207. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  208. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  209. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  210. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  211. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  212. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  213. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  214. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  215. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  216. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  217. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  218. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  219. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  220. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  221. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  222. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  223. Li X, et al. 2022. Cell. 185:1709. PubMed
  224. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  225. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  226. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  227. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  228. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  229. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  230. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  231. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  232. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  233. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  234. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  235. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  236. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  237. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  238. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  239. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  240. Cansever D, et al. 2023. Nat Immunol. . PubMed
  241. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  242. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  243. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  244. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  245. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  246. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  247. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  248. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  249. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  250. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  251. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  252. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  253. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  254. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  255. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  256. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  257. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  258. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  259. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  260. Baram T, et al. 2021. Cells. 10:. PubMed
  261. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  262. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  263. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  264. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  265. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  266. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  267. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  268. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  269. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  270. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  271. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  272. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  273. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  274. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  275. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  276. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  277. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  278. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  279. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  280. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  281. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  282. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  283. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  284. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  285. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  286. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  287. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  288. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  289. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  290. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  291. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  292. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  293. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  294. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  295. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  296. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  297. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  298. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  299. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  300. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  301. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  302. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  303. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  304. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  305. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  306. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  307. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  308. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  309. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  310. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  311. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  312. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  313. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  314. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  315. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  316. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  317. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  318. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  319. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  320. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  321. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  322. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  323. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  324. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  325. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  326. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  327. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  328. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  329. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  330. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  331. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  332. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  333. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  334. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  335. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  336. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  337. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  338. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  339. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  340. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  341. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  342. Zhang J, et al. 2018. Nature. 553:91. PubMed
  343. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  344. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  345. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  346. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  347. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  348. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  349. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  350. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  351. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  352. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  353. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  354. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  355. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  356. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  357. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  358. Kim S, et al. 2020. Autophagy. :1. PubMed
  359. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  360. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  361. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  362. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  363. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  364. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  365. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  366. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  367. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  368. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  369. Li H, et al. 2022. iScience. 25:104481. PubMed
  370. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  371. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  372. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  373. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  374. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  375. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  376. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  377. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  378. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  379. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  380. Zeng A, et al. 2020. Oncol Rep. . PubMed
  381. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  382. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  383. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  384. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  385. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  386. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  387. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  388. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  389. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  390. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235)
AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Test 17A2 5 17A2
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APC_073012
C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
  • 17A2_APC_073012
    C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100235 25 µg NOK273
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100236 100 µg NOK636
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Liu J, et al. 2019. Immunity. 50:600. PubMed
  3. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  4. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  5. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  6. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  7. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  8. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  9. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  10. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  11. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  12. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  13. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  14. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  15. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  16. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  17. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  18. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  19. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  20. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  21. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  22. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  23. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  24. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  25. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  26. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  27. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  28. Li X, et al. 2022. Cell. 185:1709. PubMed
  29. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  30. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  31. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  32. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  33. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  34. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  35. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  36. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  37. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  38. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  39. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  40. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  41. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  42. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  43. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  44. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  45. Cansever D, et al. 2023. Nat Immunol. . PubMed
  46. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  47. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  48. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  49. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  50. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  51. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  52. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  53. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  54. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  55. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  56. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  57. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  58. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  59. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  60. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  61. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  62. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  63. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  64. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  65. Baram T, et al. 2021. Cells. 10:. PubMed
  66. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  67. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  68. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  69. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  70. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  71. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  72. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  73. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  74. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  75. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  76. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  77. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  78. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  79. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  80. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  81. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  82. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  83. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  84. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  85. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  86. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  87. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  88. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  89. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  90. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  91. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  92. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  93. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  94. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  95. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  96. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  97. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  98. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  99. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  100. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  101. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  102. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  103. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  104. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  105. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  106. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  107. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  108. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  109. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  110. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  111. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  112. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  113. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  114. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  115. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  116. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  117. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  118. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  119. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  120. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  121. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  122. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  123. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  124. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  125. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  126. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  127. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  128. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  129. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  130. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  131. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  132. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  133. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  134. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  135. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  136. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  137. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  138. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  139. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  140. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  141. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  142. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  143. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  144. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  145. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  146. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  147. Zhang J, et al. 2018. Nature. 553:91. PubMed
  148. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  149. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  150. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  151. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  152. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  153. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  154. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  155. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  156. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  157. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  158. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  159. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  160. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  161. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  162. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  163. Kim S, et al. 2020. Autophagy. :1. PubMed
  164. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  165. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  166. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  167. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  168. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  169. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  170. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  173. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  174. Li H, et al. 2022. iScience. 25:104481. PubMed
  175. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  176. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  177. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  178. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  179. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  180. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  181. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  182. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  183. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  184. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  185. Zeng A, et al. 2020. Oncol Rep. . PubMed
  186. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  187. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  188. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  189. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  190. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  191. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  192. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  193. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  194. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  195. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  196. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  197. Liu J, et al. 2019. Immunity. 50:600. PubMed
  198. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  199. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  200. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  201. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  202. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  203. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  204. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  205. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  206. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  207. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  208. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  209. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  210. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  211. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  212. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  213. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  214. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  215. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  216. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  217. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  218. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  219. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  220. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  221. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  222. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  223. Li X, et al. 2022. Cell. 185:1709. PubMed
  224. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  225. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  226. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  227. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  228. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  229. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  230. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  231. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  232. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  233. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  234. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  235. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  236. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  237. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  238. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  239. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  240. Cansever D, et al. 2023. Nat Immunol. . PubMed
  241. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  242. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  243. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  244. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  245. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  246. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  247. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  248. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  249. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  250. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  251. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  252. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  253. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  254. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  255. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  256. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  257. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  258. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  259. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  260. Baram T, et al. 2021. Cells. 10:. PubMed
  261. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  262. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  263. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  264. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  265. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  266. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  267. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  268. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  269. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  270. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  271. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  272. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  273. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  274. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  275. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  276. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  277. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  278. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  279. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  280. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  281. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  282. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  283. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  284. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  285. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  286. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  287. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  288. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  289. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  290. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  291. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  292. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  293. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  294. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  295. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  296. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  297. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  298. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  299. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  300. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  301. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  302. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  303. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  304. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  305. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  306. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  307. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  308. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  309. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  310. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  311. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  312. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  313. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  314. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  315. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  316. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  317. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  318. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  319. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  320. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  321. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  322. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  323. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  324. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  325. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  326. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  327. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  328. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  329. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  330. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  331. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  332. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  333. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  334. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  335. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  336. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  337. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  338. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  339. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  340. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  341. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  342. Zhang J, et al. 2018. Nature. 553:91. PubMed
  343. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  344. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  345. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  346. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  347. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  348. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  349. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  350. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  351. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  352. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  353. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  354. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  355. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  356. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  357. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  358. Kim S, et al. 2020. Autophagy. :1. PubMed
  359. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  360. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  361. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  362. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  363. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  364. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  365. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  366. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  367. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  368. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  369. Li H, et al. 2022. iScience. 25:104481. PubMed
  370. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  371. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  372. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  373. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  374. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  375. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  376. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  377. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  378. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  379. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  380. Zeng A, et al. 2020. Oncol Rep. . PubMed
  381. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  382. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  383. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  384. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  385. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  386. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  387. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  388. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  389. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  390. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235)
AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Test 17A2 5 17A2
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account